Thaci D, Unnebrink K, Sundaram M, Sood S, Yamaguchi Y. Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study. J Eur Acad Dermatol Venereol 2015;29: 353-360.
19 yrs old Male asked about Severe Hair fall and itching on scalp, 27 doctors answered this and 170 people found it useful. Get your query answered 24*7 only on | Practo Consult
Psoriasis is a chronically recurring inflammatory disease that affects the skin, scalp, and joints. It ranges in severity from mild to severe, and patients with moderate to severe disease experience significant deterioration in quality o... M Lebwohl - 《Journal of the American Academy of Dermatol...
(HealthDay)—Secukinumab is safe and effective as a treatment for patients with extensive moderate-to-severe scalp psoriasis, according to a study published in the October issue of the Journal of the American Academy of Dermatology.
No serious treatment-related adverse events occurred. Limitations: Only short-term data are presented. Conclusion: Tildrakizumab was efficacious for the treatment of scalp psoriasis with no new safety signals. 展开 关键词: efficacy itch psoriasis safety scalp tildrakizumab 年份: 2024 ...
Physical examination revealed diffuse pink-red scaly plaques involving the scalp, forehead, trunk, buttocks, and upper and lower extremities involving >50% body surface area, with a Psoriasis Area Severity Index score of 31 (Fig 1, A). She had pitting of multiple fingernails but no dactylitis...
Frequency not reported: Reversible alopecia areata of the scalp, pustular psoriasis, acrodermatitis continua of Hallopeau Postmarketing reports: Serious skin reactions (e.g., drug reaction with eosinophilia and systemic symptoms [DRESS] syndrome)[Ref]An...
Efficacy of efalizumab in the treatment of patients with moderate to severe plaque psoriasis with hands/feet, scalp, and nails involvement: Results from a postapproval phase IIIb/IV study (control II)Efficacy of efalizumab in the treatment of patients with moderate to severe plaque psoriasis with ...
The outlook for patients with psoriasis has improved significantly over the last 10 years with the introduction of targeted therapies. Cytokines exert thei... VD Lernia,F Bardazzi - 《Drug Design Development & Therapy》 被引量: 17发表: 2016年 P094 Oral tofacitinib monotherapy for the management...
in continued improvement of outcome parameters, although no statistical difference was observed compared with patients continuing on the 100 mg tildrakizumab dose [Citation27]. Psoriasis can be located in difficult-to-treat areas, such as the scalp, face, genitals, nails, palms of hands or ...